HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Werner Poewe Selected Research

Parkinson Disease (Parkinson's Disease)

12/2015Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
11/2015Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.
11/2015Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.
9/2015Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.
8/2015Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
7/2015Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
6/2015Nonmotor symptoms in subjects without evidence of dopaminergic deficits.
4/2015Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS.
3/2015Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
1/2015Novel formulations and modes of delivery of levodopa.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Werner Poewe Research Topics

Disease

86Parkinson Disease (Parkinson's Disease)
12/2015 - 03/2003
34Multiple System Atrophy
10/2015 - 09/2002
20Parkinsonian Disorders (Parkinsonism)
01/2012 - 09/2002
18Dyskinesias (Dyskinesia)
09/2015 - 01/2004
14Dementia (Dementias)
01/2014 - 09/2002
11Neurodegenerative Diseases (Neurodegenerative Disease)
02/2015 - 08/2003
11Restless Legs Syndrome (Restless Legs)
05/2012 - 08/2005
8Disease Progression
08/2014 - 10/2003
7Dystonia (Limb Dystonia)
09/2015 - 11/2006
7Friedreich Ataxia (Friedreich's Ataxia)
08/2013 - 11/2007
6Striatonigral Degeneration
10/2015 - 08/2003
6Orthostatic Hypotension (Postural Hypotension)
09/2015 - 10/2011
6Torticollis (Wryneck)
08/2015 - 01/2002
6Nausea
08/2013 - 12/2004
5Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2012 - 09/2002
4Ataxia (Dyssynergia)
05/2014 - 06/2008
4Atherosclerosis
09/2009 - 09/2002
4Tremor (Tremors)
01/2008 - 08/2004
3REM Sleep Behavior Disorder
11/2015 - 01/2015
3Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)
10/2015 - 03/2005
3Movement Disorders (Movement Disorder)
03/2013 - 06/2006
3Gliosis
03/2013 - 12/2005
3Impulse Control Disorders (Kleptomania)
08/2012 - 05/2011
3Fatigue
10/2011 - 11/2010
2Dizziness (Lightheadedness)
02/2015 - 01/2011
2Gambling (Pathological Gambling)
01/2015 - 10/2011
2Stroke (Strokes)
01/2015 - 09/2009
2Headache (Headaches)
05/2014 - 10/2010
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 12/2004
2Hallucinations (Hallucination)
08/2013 - 08/2008
2Huntington Disease (Huntington's Disease)
05/2012 - 02/2005
2Drug Toxicity (Drug Safety)
05/2012 - 05/2008
2Constipation
10/2011 - 11/2010
2Apnea
04/2011 - 06/2009
2Cerebellar Ataxia (Dysmetria)
08/2010 - 09/2005
2Sleep Disorders
06/2009 - 09/2007
2Dystonic Disorders (Writer's Cramp)
08/2007 - 12/2005
2Inflammation
02/2005 - 05/2004
2Carotid Artery Diseases
05/2004 - 09/2002
2Infection
05/2004 - 09/2002
1Ganglion Cysts (Ganglion)
08/2015
1Urinary Tract Infections (Urinary Tract Infection)
02/2015
1Bulimia (Binge Eating)
01/2015
1Drug-Induced Dyskinesia (Dyskinesia, Drug Induced)
01/2015
1Paralysis (Palsy)
11/2014
1Dysarthria (Spastic Dysarthria)
09/2014

Drug/Important Bio-Agent (IBA)

38Levodopa (L Dopa)FDA LinkGeneric
12/2015 - 01/2004
15pramipexol (pramipexole)FDA LinkGeneric
01/2014 - 08/2006
11SynucleinsIBA
11/2015 - 02/2011
11alpha-SynucleinIBA
02/2011 - 08/2003
10Biological Markers (Surrogate Marker)IBA
01/2015 - 10/2003
10Dopamine Agonists (Dopamine Agonist)IBA
07/2013 - 09/2003
9rasagiline (Azilect)FDA Link
04/2015 - 05/2005
8Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2015 - 10/2003
8ErythropoietinFDA Link
08/2013 - 11/2007
8N 0437FDA Link
07/2013 - 07/2008
7Dopamine (Intropin)FDA LinkGeneric
01/2015 - 02/2005
7rivastigmine (Exelon)FDA LinkGeneric
01/2014 - 12/2004
6Carbidopa (Lodosyn)FDA LinkGeneric
12/2015 - 07/2010
6frataxinIBA
08/2013 - 10/2008
5entacapone (Comtan)FDA Link
12/2015 - 01/2004
5Botulinum Toxins (Botulinum Toxin)IBA
09/2014 - 01/2002
5Amantadine (Aman)FDA LinkGeneric
11/2013 - 07/2010
5ropinirole (Requip)FDA LinkGeneric
08/2012 - 08/2006
4salicylhydroxamic acid (SHAM)IBA
08/2015 - 11/2006
4IronIBA
07/2015 - 08/2005
4Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2013 - 08/2011
43-nitropropionic acidIBA
05/2012 - 08/2003
4Pergolide (Permax)FDA Link
10/2011 - 08/2006
3pamidronate (APD)FDA LinkGeneric
01/2014 - 09/2002
3serum P-component (CIt)IBA
11/2012 - 04/2011
3Monoamine Oxidase (MAO)IBA
08/2012 - 04/2008
3Selegiline (E250)FDA LinkGeneric
08/2012 - 05/2005
3Antidepressive Agents (Antidepressants)IBA
10/2011 - 02/2010
3cabergolineFDA LinkGeneric
10/2011 - 08/2006
3Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
12/2010 - 06/2004
2BenserazideIBA
12/2015 - 12/2010
2Peroxidase (Myeloperoxidase)IBA
10/2015 - 05/2012
2perampanelIBA
02/2012 - 05/2010
2Clozapine (Clozaril)FDA LinkGeneric
10/2011 - 10/2011
2OxygenIBA
04/2011 - 06/2009
2Minocycline (Cyclops)FDA LinkGeneric
01/2010 - 10/2004
2Cholinesterase Inhibitors (Anticholinesterases)IBA
02/2009 - 09/2003
2HomocysteineIBA
08/2008 - 12/2005
2EnzymesIBA
07/2008 - 02/2005
2RTI 55 (Iometopane)IBA
08/2006 - 07/2005
1DroxidopaIBA
09/2015
1ApomorphineIBA
09/2015
1AntibodiesIBA
08/2015
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2015
1Adenosine A2 Receptor AntagonistsIBA
08/2014

Therapy/Procedure

10Deep Brain Stimulation
08/2015 - 06/2006
10Activities of Daily Living (ADL)
05/2014 - 12/2004
3Injections
09/2014 - 08/2004
3Transdermal Patch
08/2011 - 01/2010
3Transplantation (Transplant Recipients)
09/2009 - 12/2005
3Transplants (Transplant)
09/2009 - 05/2005
2Aftercare (After-Treatment)
01/2013 - 08/2011
2Therapeutics
08/2012 - 05/2011
2Homologous Transplantation (Allograft)
09/2009 - 12/2005